LACOSAMIDE STRAGEN 10 mg/ml, solution for infusion 5 ampoules of 20 ml
Active ingredients: Lacosamide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusion5 ampoules of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LACOSAMIDE STRAGEN 10 mg/mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 20 ml
- Marketing authorisation holder
- STRAGEN-FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68849070CIP73025429CIP133400930254295Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LACOSAMIDEsolution | 10 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.